The RILONACEPT NLRP3 brand, founded in 2009 (United States), from 16 sister brands and 2214 competing brands. RILONACEPT NLRP3 is owned by Regeneron Pharmaceuticals, listed on the stock exchange of New York The sector of RILONACEPT NLRP3 is Biotechnology.

RILONACEPT NLRP3 is a brand of Regeneron Pharmaceuticals (REGN) Share price

International deposit : 2009 Business sector Biotechnology

Share price and profitability of the share Regeneron Pharmaceuticals (RILONACEPT NLRP3)

Buy Regeneron Pharmaceuticals share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 906.54

Portfolio valuation
Regeneron Pharmaceuticals (RILONACEPT NLRP3) over 5 years* USD 2,380.45

Stock market history Regeneron Pharmaceuticals (RILONACEPT NLRP3)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Regeneron Pharmaceuticals

See more brands of Regeneron Pharmaceuticals

Rival brands
RILONACEPT NLRP3

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS